drugdeliverybusiness3h
Vivani can begin first-in-human GLP-1 implant trial in Australia following regulatory approval
Vivani Medical today announced that Australian authorities approved a first-in-human clinical trial for its subdermal GLP-1 ...
drugdeliverybusiness4h
CereVasc data shows that eShunt could help deliver gene therapies to the central nervous system
CereVasc shared data from a study demonstrating that its eShunt system may help deliver gene therapies to the central nervous ...
drugdeliverybusiness1d
PCI Pharma Services makes $365M investment in drug delivery device manufacturing
PCI Pharma Services announced that it's investing more than $365 million in infrastructure to support assembly and packaging ...
drugdeliverybusiness1d
RenovoRx to increase production of RenovoCath catheter delivery system
RenovoRx announced today that it plans to increase the production of its RenovoCath catheter-based delivery system.
drugdeliverybusiness3d
Ypsomed reports positive outcomes with automated insulin delivery for maternal health
Ypsomed reports positive outcomes from a randomized trial of its closed-loop insulin delivery technology during type 1 ...
drugdeliverybusiness3d
Dexcom, Retta, Beyond Type 2 team up to raise glucose awareness
Dexcom (Nasdaq:DXCM) today announced a collaboration to establish National Glucose Awareness Week from Sept. 23-29, 2024.
drugdeliverybusiness7d
Tandem wins clearance for t:slim X2 pump with Eli Lilly fast-acting insulin in Europe
t:slim X2 Insulin Pump from Tandem Diabetes Care with Abbott’s Freestyle Libre 2 Plus sensor. [Image courtesy of Abbott/Tandem Diabetes Care] Tandem Diabetes Care (Nasdaq:TNDM) announced today that it ...
drugdeliverybusiness7d
Fresenius Kabi recalls and removes some Ivenix infusion pump administration sets from market
The Ivenix infusion system. [Image courtesy of Fresenius Kabi] The FDA issued a notice outlining a serious recall of Ivenix infusion pump administration sets from Fresenius Kabi. This recall involves ...